32964397|t|Nitric Oxide/Cyclic GMP-Dependent Calcium Signalling Mediates IL-6- and TNF-alpha-Induced Expression of Glial Fibrillary Acid Protein.
32964397|a|Astrocyte activation is characterized by hypertrophy with increased glial fibrillary acidic protein (GFAP), whose expression may involve pro-inflammatory cytokines. In this study, the effects of pro-inflammatory IL-6 and TNF-alpha and anti-inflammatory cytokines IL-4 and IL-10 on nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) signalling, intracellular calcium concentration ([Ca2+]i) and GFAP expression were investigated. In human glioblastoma astrocytoma U-373 MG cells, IL-6 and TNF-alpha, but not IL-4 or IL-10, increased iNOS, cGMP, [Ca2+]i and GFAP expression. The inhibitors of iNOS (1400 W), soluble guanylyl cyclase (ODQ) and IP3 receptors (ryanodine and 2-APB) reversed the increase in cGMP or [Ca2+]i, respectively, and prevented GFAP expression. In rat striatal slices, IL-6 and TNF-alpha, at variance with IL-4 and IL-10, promoted a concentration-dependent increase in Ca2+ efflux, an effect prevented by 1400 W, ODQ and RY/2APB. These data were confirmed by in vivo studies, where IL-6, TNF-alpha or the NO donor DETA/NO injected in the striatum of anaesthetised rats increased cGMP levels and increased GFAP expression. The present findings point to NO/cGMP-dependent calcium signalling as part of the mechanism mediating IL-6- and TNF-alpha-induced GFAP expression. As this process plays a fundamental role in driving neurotoxicity, targeting NO/cGMP-dependent calcium signalling may constitute a new approach for therapeutic interventions in neurological disorders.
32964397	0	12	Nitric Oxide	Chemical	MESH:D009569
32964397	13	23	Cyclic GMP	Chemical	MESH:D006152
32964397	34	41	Calcium	Chemical	MESH:D002118
32964397	62	66	IL-6	Gene	3569
32964397	72	81	TNF-alpha	Gene	7124
32964397	176	187	hypertrophy	Disease	MESH:D006984
32964397	203	234	glial fibrillary acidic protein	Gene	2670
32964397	236	240	GFAP	Gene	2670
32964397	276	288	inflammatory	Disease	MESH:D007249
32964397	334	346	inflammatory	Disease	MESH:D007249
32964397	347	351	IL-6	Gene	3569
32964397	356	365	TNF-alpha	Gene	7124
32964397	375	387	inflammatory	Disease	MESH:D007249
32964397	398	402	IL-4	Gene	3565
32964397	407	412	IL-10	Gene	3586
32964397	416	428	nitric oxide	Chemical	MESH:D009569
32964397	434	464	cyclic guanosine monophosphate	Chemical	MESH:D006152
32964397	466	470	cGMP	Chemical	MESH:D006152
32964397	498	505	calcium	Chemical	MESH:D002118
32964397	522	526	Ca2+	Chemical	-
32964397	534	538	GFAP	Gene	2670
32964397	572	577	human	Species	9606
32964397	578	602	glioblastoma astrocytoma	Disease	MESH:D005909
32964397	603	611	U-373 MG	CellLine	CVCL:2818
32964397	619	623	IL-6	Gene	3569
32964397	628	637	TNF-alpha	Gene	7124
32964397	647	651	IL-4	Gene	3565
32964397	655	660	IL-10	Gene	3586
32964397	672	676	iNOS	Gene	51477
32964397	678	682	cGMP	Chemical	MESH:D006152
32964397	685	689	Ca2+	Chemical	-
32964397	696	700	GFAP	Gene	2670
32964397	731	735	iNOS	Gene	51477
32964397	772	775	ODQ	Chemical	-
32964397	796	805	ryanodine	Chemical	MESH:D012433
32964397	810	815	2-APB	Chemical	MESH:C109986
32964397	842	846	cGMP	Chemical	MESH:D006152
32964397	851	855	Ca2+	Chemical	-
32964397	887	891	GFAP	Gene	2670
32964397	907	910	rat	Species	10116
32964397	928	932	IL-6	Gene	24498
32964397	937	946	TNF-alpha	Gene	24835
32964397	965	969	IL-4	Gene	287287
32964397	974	979	IL-10	Gene	3586
32964397	1028	1032	Ca2+	Chemical	-
32964397	1072	1075	ODQ	Chemical	-
32964397	1080	1087	RY/2APB	Chemical	-
32964397	1141	1145	IL-6	Gene	24498
32964397	1147	1156	TNF-alpha	Gene	24835
32964397	1173	1177	DETA	Chemical	MESH:D003671
32964397	1223	1227	rats	Species	10116
32964397	1238	1242	cGMP	Chemical	MESH:D006152
32964397	1264	1268	GFAP	Gene	24387
32964397	1314	1318	cGMP	Chemical	MESH:D006152
32964397	1329	1336	calcium	Chemical	MESH:D002118
32964397	1383	1387	IL-6	Gene	3569
32964397	1393	1402	TNF-alpha	Gene	24835
32964397	1411	1415	GFAP	Gene	2670
32964397	1480	1493	neurotoxicity	Disease	MESH:D020258
32964397	1508	1512	cGMP	Chemical	MESH:D006152
32964397	1523	1530	calcium	Chemical	MESH:D002118
32964397	1605	1627	neurological disorders	Disease	MESH:D009461
32964397	Positive_Correlation	2670	3569
32964397	Positive_Correlation	MESH:D006152	3569
32964397	Association	MESH:D002118	MESH:D009569
32964397	Association	MESH:D002118	MESH:D006152
32964397	Association	MESH:D006152	MESH:D009461
32964397	Association	MESH:D002118	3569
32964397	Association	MESH:D002118	2670
32964397	Positive_Correlation	3569	51477
32964397	Positive_Correlation	24835	2670
32964397	Negative_Correlation	MESH:C109986	2670
32964397	Association	MESH:D006152	7124
32964397	Positive_Correlation	51477	7124
32964397	Positive_Correlation	MESH:D007249	2670
32964397	Positive_Correlation	MESH:D006152	2670
32964397	Positive_Correlation	24387	24498
32964397	Association	MESH:D006152	MESH:D020258
32964397	Association	MESH:D002118	MESH:D020258
32964397	Association	MESH:D009569	7124
32964397	Positive_Correlation	MESH:D003671	MESH:D006152
32964397	Positive_Correlation	MESH:D006152	24498
32964397	Positive_Correlation	2670	7124
32964397	Association	MESH:D009569	3569
32964397	Association	MESH:D002118	7124
32964397	Positive_Correlation	MESH:D003671	24387
32964397	Negative_Correlation	MESH:D012433	2670
32964397	Association	MESH:D002118	MESH:D009461
32964397	Positive_Correlation	MESH:D006152	24835

